Czechia, April 24 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Antineoplastic and immunomodulating agents - Medicinal preparations of ATC groups L04A* and L01XG03. The value of the contract is worth 5260704420 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....